BMJ Open Respiratory Research

Papers
(The median citation count of BMJ Open Respiratory Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma72
Nocturnal gastro-oesophageal reflux and respiratory symptoms are increased in sleep apnoea: comparison with the general population66
Reference equations for DLNO and DLCO in Mexican Hispanics: influence of altitude and race64
Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England56
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire50
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients41
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study40
Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors34
Correction: Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study32
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis31
Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study31
Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation30
Daily SARS-CoV-2 testing after travel-related close contact notifications during elite sporting events hosted in the UK: a longitudinal study30
Uptake and 4-week outcomes of an ‘opt-out’ smoking cessation referral strategy in a London-based lung cancer screening setting30
Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation28
Healthcare experience of adults with COPD during the COVID-19 pandemic: a rapid review of international literature28
Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards26
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis26
Physiological demands of singing for lung health compared with treadmill walking26
Patient and public partnership at BMJ Open Respiratory Research25
Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study24
New method to measure interbreath intervals in infants for the assessment of apnoea and respiration24
Lung cancer in recipients after lung transplant: single-centre experience and literature review23
Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study22
Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis22
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life21
Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors21
Comparison of the efficacy of novel two covering methods for spontaneous pneumothorax: a multi-institutional study21
Objective measurement of lung volume recruitment therapy: laboratory and clinical validation19
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant18
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD18
Early experiences of the Your COVID Recovery®digital programme for individuals with long COVID17
Canonical correlation analysis of factors that influence quality of life among patients with chronic obstructive pulmonary disease based on QLICD-COPD (V2.0)17
Physiological changes related to 10 weeks of singing for lung health in patients with COPD17
Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy17
Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study17
Correlation of lung function with ultra-low-dose CT-detected lung parenchymal abnormalities: a cohort study of 1344 asbestos exposed individuals16
Differences in risk indicators associated with electronic cigarette use and tobacco smoking among adolescents and young people in Nigeria16
Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey16
Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their f16
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials15
Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study15
Lower geriatric nutritional risk index is associated with a higher risk of all-cause mortality in patients with chronic obstructive pulmonary disease: a cohort study from the National Health and Nutri14
Signs and symptoms of acute pulmonary embolism and their predictive value for all-cause hospital death in respect of severity of the disease, age, sex and body mass index: retrospective analysis of th14
CT airway remodelling and chronic cough14
Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshi14
Registry-based study in people with cystic fibrosis and anR117Hvariant treated with ivacaftor14
Phenotypic characteristics of asthma and morbidity are associated with distinct longitudinal changes in L-arginine metabolism13
Comparison of obstructive sleep apnoea prevalence and severity across WHO pulmonary hypertension groups13
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes13
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)13
Lung transplantation for interstitial lung disease: evolution over three decades13
Development and validation of a novel questionnaire to describe and assess sensations and triggers associated with refractory and unexplained chronic cough12
Patient pathways for four major chronic respiratory diseases in England between 2008 and 202112
Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study12
National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002−202212
Physical activity, sedentary behaviour, and childhood asthma: a European collaborative analysis12
Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study12
Sex-specific alterations in pulmonary metabolic, xenobiotic and lipid signalling pathways after e-cigarette aerosol exposure during adolescence in mice11
Exploration of preferences among people with COPD to inform resource allocation: a discrete choice experiment study11
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study11
Systematic review of physiological and psychological outcomes of surgery for pectus excavatum supporting commissioning of service in the UK11
6-month regimen of isoniazid prevention therapy for tuberculosis among people living with human immunodeficiency virus in minority areas of China: a 3-year prospective cohort study11
Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx11
Association of non-obstructive dyspnoea with all-cause mortality and incident chronic obstructive pulmonary disease: a systematic literature review and meta-analysis10
Impaired lung function and lung cancer risk in 461 183 healthy individuals: a cohort study10
Lack of racial and ethnic disparities in mortality in minority patients hospitalised with COVID-19 in a mid-Atlantic healthcare system10
Bagasse dust exposure and chronic respiratory symptoms among workers in the Metehara and Wonji sugar factories in Ethiopia: a longitudinal study design10
REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetr10
Risk of exacerbation and mortality in asthma: a 10-year retrospective financial database analysis of the Hungarian Health Insurance Fund10
Validity and reliability of outcome measures to assess dysfunctional breathing: a systematic review10
Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical c10
Prevalence, Medicaid use and mortality risk of low FEV1in adults aged 20–35 years old in the USA: evidence from a population-based retrospective cohort study10
Characteristics and outcomes of patients enrolled in the Connect 360 benralizumab patient support programme in the UK: a retrospective cohort study10
Developing and validating prediction models for severe exacerbations and readmissions in patients hospitalised for COPD exacerbation (SERCO) in China: a prospective observational study10
Chronic respiratory disease observatory for Africa (CHEST-Africa): study protocol for the prevalence, determinants and economic impacts of asthma and COPD in Africa9
Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases9
Extracorporeal CO2removal in acute exacerbation of COPD unresponsive to non-invasive ventilation9
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study9
Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case–control study9
Predicting parameters of airway dynamics generated from inspiratory and expiratory plethysmographic airway loops, differentiating subtypes of chronic obstructive diseases9
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance9
Performance of popular pulse oximeters compared with simultaneous arterial oxygen saturation or clinical-grade pulse oximetry: a cross-sectional validation study in intensive care patients9
Association between COVID-19 severity and tobacco smoking status: a retrospective cohort study using propensity score matching weights analysis9
Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost9
Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis9
Use of oral moist tobacco (snus) in puberty and its association with asthma in the population-based RHINESSA study9
Specialist pneumonia intervention nurse service improves pneumonia care and outcome8
Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis8
Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure8
Understanding clinical decision-making in mesothelioma care: a mixed methods study8
Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis8
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities8
Impacts of regular physical activity on hospitalisation in chronic obstructive pulmonary disease: a nationwide population-based study8
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial8
Association of sleep apnoea risk and aortic enlargement in Marfan syndrome8
Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry8
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation8
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis8
Definitions of pulmonary exacerbation in people with cystic fibrosis: a scoping review8
Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension8
Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience7
129Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome7
Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin7
Frailty assessment for COVID-19 follow-up: a prospective cohort study7
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration7
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial7
Exploration of therapists’ views of practice within critical care7
Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients7
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial7
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response7
Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 20217
Reflexive thematic analysis exploring stakeholder experiences of virtual pulmonary rehabilitation (VIPAR)7
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study7
Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial7
Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study7
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry7
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in Eng7
Symptomatic, biochemical and radiographic recovery in patients with COVID-197
COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation7
Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study7
Enhanced airway sensory nerve reactivity in non-eosinophilic asthma7
Measurement of breathing in patients with post-COVID-19 using structured light plethysmography (SLP)7
Stability in eosinophil categorisation during subsequent severe exacerbations of COPD7
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD7
Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial7
Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia7
British Thoracic Society survey of the career intentions of respiratory medicine specialty trainees in the UK7
Trending peripheral venous PCO2in patients with respiratory failure using mathematically arterialised venous blood gas samples6
Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation6
Compensatory function change by segment-counting method in predicted postoperative pulmonary function at 1 year after surgery: systematic review and meta-analysis6
Sequential exploratory mixed-method research of an eHealth intervention on blood pressure, sleep quality and physical activity in obstructive sleep apnoea: rationale and methodology of the Moore4Medic6
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial6
Ventilator performances for non-invasive ventilation: a bench study6
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda6
Pim1 inactivating induces RUNX3 upregulation that improves/alleviates airway inflammation and mucus hypersecretion in vitro and in vivo6
Digitally recorded and remotely classified lung auscultation compared with conventional stethoscope classifications among children aged 1–59 months enrolled in the Pneumonia Etiology Research for Chil6
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study6
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases6
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy6
Defining hypoxaemia from pulse oximeter measurements of oxygen saturation in well children at low altitude in Bangladesh: an observational study6
Patient perspectives on knowledge gaps in hypersensitivity pneumonitis6
Bile acids in the lower airways is associated with airway microbiota changes in chronic obstructive pulmonary disease: an observational study6
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children6
Research priorities for progressive pulmonary fibrosis in the UK6
Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis5
COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation5
Feasibility of dynamic chest radiography to calculate lung volumes in adult people with cystic fibrosis: a pilot study5
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany5
Pulmonary sequelae in 2-year-old children after hospitalisation for respiratory syncytial virus lower respiratory tract infection during infancy: an observational study5
Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study5
Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-195
Patient compliance and satisfaction with a new forehead device for positional obstructive sleep apnoea treatment: a post hoc analysis of a randomised controlled trial5
Lung ultrasound volume sweep imaging for respiratory illness: a new horizon in expanding imaging access5
Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study5
What if… your research is suddenly affiliated with a tobacco manufacturing company?5
Needs assessment for introducing pulmonary rehabilitation for chronic obstructive pulmonary disease management in a rural Indian setting: a qualitative study5
Clinical utility of elective paediatric flexible bronchoscopy and impact on the quality of life: protocol for a single-centre, single-blind, randomised controlled trial5
Association of high-sensitivity CRP and FEV1%pred: a study on non-pulmonary disease in a population in Beijing, China5
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study5
Rapidly and slowly progressive neuromuscular disease: differences in pulmonary function, respiratory tract infections and response to lung volume recruitment therapy (LVR)5
Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy5
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy5
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study5
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study5
Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey5
Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?5
Whole-course management of chronic obstructive pulmonary disease in primary healthcare: an internet of things-enabled prospective cohort study in China5
Association between air pollutant exposure, body water distribution and sleep disorder indices in individuals with low-arousal-threshold obstructive sleep apnoea5
Long-term cohort study of patients presenting with hypercapnic respiratory failure5
Transitioning from hospital to home with non-invasive ventilation: who benefits? Results of a cohort study5
Influencing factors of sedentary behaviour in people with chronic obstructive pulmonary disease: a systematic review5
Association of alpha globin gene copy number with exhaled nitric oxide in a cross-sectional study of healthy Black adults5
Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort stu5
Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005–2018: a Canad5
Contribution of collagen XIII to lung function and development of pulmonary fibrosis5
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates5
Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis5
Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis5
Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers5
Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia5
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA5
Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss5
Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 20195
Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study5
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer5
Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan5
A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis5
Novel 3D-based deep learning for classification of acute exacerbation of idiopathic pulmonary fibrosis using high-resolution CT4
Effects of indoor air pollution on clinical outcomes in patients with interstitial lung disease: protocol of a multicentre prospective observational study4
Cardiovascular outcomes following hospitalisation for exacerbation of bronchiectasis: a territory-wide study4
Trajectory of inhaled cadmium ultrafine particles in smokers4
Evaluation of energy intake by brief-type self-administered diet history questionnaire among male patients with stable/at risk for chronic obstructive pulmonary disease4
Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality4
Breathlessness dimensions association with physical and mental quality of life: the population based VASCOL study of elderly men4
BTS clinical statement for the diagnosis and management of ocular tuberculosis4
COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study4
Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access4
Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice4
Home-based pulmonary rehabilitation early after hospitalisation in COPD (early HomeBase): protocol for a randomised controlled trial4
Characteristics and phenotypes of a COPD cohort from referral hospital clinics in Uganda4
Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada4
Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis4
Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease4
Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis4
Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms4
Role of IPF genetic risk loci in post-COVID-19 lung abnormalities: a cohort study4
Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review4
Real-world implementation of the National Early Warning Score-2 in an acute respiratory unit4
Qualitative study exploring the views and perceptions of parents/carers of young children with CF regarding the introduction of CFTR modulator therapy (The REVEAL study; PaRents pErspectiVEs of KAftri4
Clinical characteristics of patients with a risk of pulmonary artery hypertension secondary to ARDS in a high-altitude area4
Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode4
Asthma, rhinitis and eczema symptoms in Quito, Ecuador: a comparative cross-sectional study 16 years after ISAAC4
Hospitalisations and fatality due to respiratory diseases according to a national database in Brazil: a longitudinal study4
Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK4
Medication use of Canadians with chronic obstructive pulmonary disease: a cohort study4
Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis4
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase)4
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resecta4
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol4
Lung function and onset of cardiometabolic diseases in the longitudinal Burden of Obstructive Lung Disease study4
Effect of a postoperative home-based exercise and self-management programme on physical function in people with lung cancer (CAPACITY): protocol for a randomised controlled trial4
British Thoracic Society Quality Standard for Clinically Significant Bronchiectasis in Adults 20224
Association between serum uric acid/serum creatinine ratios and lung function in the general American population: National Health and Nutrition Examination Survey (NHANES), 2007–20124
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern4
Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study4
Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases4
Feasibility of home initiation of an airway clearance device (SIMEOX) by telecare in people with non-cystic fibrosis bronchiectasis: a pilot study3
SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic3
Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial3
Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis3
Association of body mass index with morbidity in patients hospitalised with COVID-193
Sendaway capillary NT-proBNP in pulmonary hypertension3
Performance evaluation of human cough annotators: optimal metrics and sex differences3
Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework3
Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in respiratory clinics: an open-label randomised controlled trial3
Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers3
The ‘ABC’ of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians – a systematic review3
Adherence to COVID-19 preventive measures and associated factors among high school students in Northwest Ethiopia: a cross-sectional study3
Optimal resection rate for lung cancer in the UK: how high should we go?3
Perinatal and early life factors and asthma control among preschoolers: a population-based retrospective cohort study3
High-intensity non-invasive ventilation during exercise-training versus without in people with very severe COPD and chronic hypercapnic respiratory failure: a randomised controlled trial3
In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study3
Changes in interpretation of spirometry by implementing the GLI 2012 reference equations: impact on patients tested in a hospital-based PFT lab in a large metropolitan city3
Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’3
Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study3
Beyond direct costs: individual and societal financial burden of asthma in young adults in a Danish nationwide study3
Lung fluid content during 6MWT in patients with COPD with and without comorbid heart failure3
Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study3
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)3
0.070823907852173